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A 65-year-old Caucasian man with myelodysplasia was admitted
with autoimmune hemolytic anemia and a Hb of 5.6 g/dL. The
patient’s serum contained anti-K; the DAT on the patient’s RBCs
reacted 3+ with anti-IgG and 3+ with anti-C3d. K– RBC units were
transfused, but there was no sustained increase in Hb level. The
samples were referred to the reference laboratory of the National
Blood Service. The DAT results remained the same, with anti-K
detected only in the serum. An eluate prepared from the patient’s
DAT-positive RBCs revealed anti-Kpb specificity. This study reports
an unusual case of autoanti-Kpb, which is different from previously
published cases in that no free anti-Kpb was detectable in the
serum. Immunohematology 2005;21:119–121.
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Autoantibodies found in patients with warm
autoimmune hemolytic anemia (WAIHA) often show a
RBC specificity related to the Rh system. The first
example of this type of autoantibody was described by
Race and Sanger.1 Although antibodies to other high-
prevalence antigens have been reported, such as
autoanti-AnWj, -Co3, -Dib, -Ena, -Ge, -Hro, -Kpb, -K13, -Kx,
-LW, -‘N,’ -Rh34, -Sc1, -Sc3, -U, -Vel, and -Wrb, they are rare.
We report an unusual case of autoanti-Kpb, which is
different from previously published cases2–4 in that no
free anti-Kpb was detectable in the patient’s serum.
Kp(b–) RBCs were issued for further transfusion
support. Transfusion of presumably Kp(b+) RBCs did
not result in a sustained increase in Hb, therefore
Kp(b–) RBCs were issued for further transfusion
support. Subsequent transfusions were uneventful and
achieved prolonged Hb increment.
Case Report
A sample from a 65-year-old Caucasian man with
myelodysplasia, on regular transfusion support, was
tested to be Group O, R1R2 with anti-K in the serum.
Later the patient had colitis and developed acute
autoimmune hemolytic anemia (AIHA) with a positive
DAT. The patient was transfused with K– RBCs but
there was no sustained response in Hb level. The
samples were submitted to the Reference Laboratory of
the National Blood Service (NBS), North London, for
investigation.
Materials and Methods
Antigen typing for ABO, Rh, and K were performed
by standard tube technique. Anti-A and anti-B reagents
were from Diagnostic Scotland, Edinburgh, Scotland;
anti-D reagents (RUM1 and BS226) were from NBS
Reagents, Cambridge, United Kingdom; monoclonal
anti-Rh (anti-C, -E, -c, and -e ), and anti-K were from
BIOSCOT (now Serologicals), Ltd., Livingston, Scotland.
Antibody identification was performed by standard
tube LISS-IAT (LISS from Inverclyde Biologicals,
Bellshill, Scotland). The patient’s serum was tested
with an in-house panel of RBCs to determine antibody
specificities. The manual polybrene technique was also
used to determine additional antibody specificities.
The 0.05% working solution of polybrene, the
resuspending solution, and low–ionic-strength medium
were prepared in house according to Methods in
Immunohematology.5 The DAT was performed with
polyspecific AHG and monospecific anti-IgG and anti-
C3d reagents (NBS Reagents). An eluate was prepared
from the patient’s RBCs using chloroform following the
protocol in Methods in Immunohematology5 and was
tested with in-house selected-RBC panels and with
RBCs from the frozen inventory for antibody
identification. Chloroquine diphosphate (CDP, 200
mg/mL, pH 5.0 ± 0.1) was prepared by NBS Reagents.
CDP treatment consisted of adding four volumes of
CDP to one volume of washed packed RBCs, mixing,
and incubating at 20°C for a maximum of 2 hours. A
DAT using anti-IgG was performed on the CDP-treated
RBCs every 30 minutes during this incubation to
ensure the effectiveness of the CDP treatment.
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Results
A posttransfusion sample from the patient showed
the RBCs to be Group O, R1R2 and to have a positive
DAT, reacting 3+ with both anti-IgG and anti-C3d. Tests
by routine LISS-IAT, saline, and manual polybrene
techniques revealed anti-K in the patient’s serum. An
eluate was prepared using a chloroform method and
autoanti-Kpb was detected, reacting 3+. After CDP
treatment of the patient’s RBCs, they were typed as
Kp(b+) (Table 1). The patient was transfused with two
units of K–, Kp(b–) RBCs. Three additional units of K–,
Kp(b–) RBCs were transfused two days later. All of the
units were frozen-recovered, deglycerolized RBCs from
the same donor. The transfusions were well tolerated
and the patient recovered from this hemolytic episode.
One month later, a DAT performed on the patient’s
RBCs was still positive (anti-IgG 3+, anti-C3d weak
positive), and anti-K was detected by LISS-IAT in the
patient’s serum in addition to a weak autoantibody
detectable by manual polybrene technique only.
Autoanti-Kpb was not apparent in the serum or eluate.
Although all of the RBCs transfused to the patient were
K–, anti-K was eluted from the patient’s RBCs, probably
due to the Matuhasi-Ogata phenomenon, in which
alloantibodies are nonspecifically bound to the RBC
along with autoantibody (Table 1).
Discussion
An autoantibody with Kpb specificity has been
reported in AIHA and appears to be rare. In all
previously reported cases of AIHA with autoanti-Kpb
specificity, free autoantibody was always detectable in
the serum. In the case we describe,no free autoanti-Kpb
was detected, distinguishing it from the other published
cases. The identification of autoanti-Kpb in this case was
fortuitous, as the routine panel of reagent RBCs used at
the time had one example of Kp(b–) RBCs, which
helped to define the autoantibody specificity.
Most autoantibody specificities are Rh-related, such
as anti-nl, anti-pdl,and anti-dl,6 and it is reported that up
to 50 percent of antibody specificities in WAIHA are in
these groups.7 Usually it is not necessary to honor the
specificity of the autoantibody when selecting RBCs
for transfusion. The use of a high-prevalence antigen-
negative panel is often not indicated and the ability to
resolve these specificities is limited by the availability
of suitably typed reagent RBCs, such as Rhnull and Rh
deletion. Extensive investigations are only performed
in selected rare circumstances. In our institution, Rh-
and K-matched RBCs are selected and issued for
transfusion in cases of AIHA.
The patient in this case had pre-existing
myelodysplasia, developing colitis, and infection.
Although disease-associated transient suppression of
Kell antigens has been reported,8–10 no suppression of
the Kpb antigen was observed in this case. A positive
result was obtained in the Kpb typing after CDP
treatment of the patient’s RBCs. This finding may,
however, be due to the timing of the test sample.
There are a few case reports of autoantibody with
Kpb specificity described in the literature. Marsh et al.11
reported a case of AIHA, due to anti-Kpb, in a patient
who had a severe hemolytic transfusion reaction after
receiving Kp(b+) RBCs. As previous transfusions with
K– RBCs had not resulted in a sustained Hb increment,
Kp(b–) RBCs were selected; transfusion was uneventful
and an excellent hematologic response was achieved.
Win et al.3 also reported a rare case of AIHA in a 12-
week-old infant. Autoanti-Kpb was identified in the
infant’s serum. Initially the infant was transfused with
Kp(b+) RBCs and had recurrent hemolytic transfusion
reactions. Pronounced jaundice was noted and there
was no sustained increase in Hb level after transfusion.
The reference laboratory detected autoanti-Kpb in the
serum and transfusion with Kp(b–) RBCs gave an
excellent result with no further reactions.
Table 1. Summary of laboratory findings*
Hb Antibody Antibody
Date (g/dL) (serum) (eluate) Anti-IgG Anti-C3d Phenotype of patient RBC units provided
5/15/98 NA Anti-K NT NT NT K– 2 units K–
6/4/98 5.6 Anti-K (5+)† Anti-Kpb (3+) 3+ 3+ K–, Kp(b+) 2 units R2r, K–, Kp(b–)
6/11/98 7.0 NT NT NT NT – 3 units R2r, K–, Kp(b–)
7/10/98 NA Anti-K (5+)† Anti-K (2+)§ 3+ (+) – None
weak autoantibody
by LIP‡
*NA = not available, NT = not tested
†Refer to Table 2
‡LIP = manual polybrene technique
§Anti-K probably due to Matuhasi-Ogata phenomenon
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AIHA and autoanti-Kpb
The use of Rh- and K-matched RBCs for AIHA
patients is standard practice in our organization and
only rarely are RBCs that are negative for antigens
against which autoantibodies have been detected
selected for transfusion.12 In the case we describe
here, because of the unusual nature of the
autoantibody, and because of the lack of a response to
the transfusion of Kp(b+) RBCs, we selected frozen-
recovered, deglycerolized Kp(a+b–) RBCs for
transfusion during the hemolytic episodes.
AIHA with autoanti-Kpb specificity is rare and our
case supports previous findings that Kp(b–) RBCs
should be selected for patients with Kpb autoantibodies
for transfusion support.3,11
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Table 2. Grading system for hemagglutination
Reaction
grade Score Description
5+ 12 Cell button remains in one clump or
dislodges into a few large clumps,
macroscopically visible
4+ 10 Cell button dislodges into numerous large
clumps, macroscopically visible
3+ 8 Cell button dislodges into many small
clumps, macroscopically visible
2+ 5 Cell button dislodges into finely granular but
definite small clumps, macroscopically visible
1+ 3 Cell button dislodges into very small
agglutinates, these are more distinct if the
tube is left on its side to allow the cells to
settle, macroscopically visible
w 2 Grainy appearance, agglutinates best seen
microscopically
0 0 Negative result
